BioNTech SE - ADR vs Peloton Interactive Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Peloton Interactive Inc trades at $5.63 (market cap $2.46B). The key difference: BioNTech SE - ADR is far larger — about 9.5× Peloton Interactive Inc's market cap, and Peloton Interactive Inc is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | PTON | |
|---|---|---|
Market Cap | $23.31B | $2.46B |
Sector | Health | Consumer Cyclical |
52-Week High | $119.34 | $9.00 |
52-Week Low | $83.89 | $3.71 |
Enterprise Value | $6.60B | $2.96B |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →Peloton Interactive Inc operates an interactive fitness platform. It operates its business in two reportable segments: Connected Fitness Products and Subscription. Connected Fitness Product revenue consists of sales of bike and tread and related accessories, associated fees for delivery and installation, and extended warranty agreements. Subscription revenue consists of revenue generated from monthly Connected Fitness Subscription and Digital Subscription. The company generates the majority of the revenue from the sale of Connected Fitness Products.
Read more on PTON →